Company Overview
- Website
- reglagene.com
- Phone
- (520) 235-0365
- Employees
- 8
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$3B
Recent News & Media
RGN-6024 has enhanced brain penetrance in brain cancer models
- Jun 4, 2025
- bioworld.com
Tucson's Top 10 Startups That Tech Professionals Should Watch Out For in 2025
- Feb 12, 2025
- nucamp.co
Reglagene patents potential therapy for treating cancer
- Sep 25, 2024
- bioworld.com
TMC Innovation Announces 2024 Accelerator for Cancer Therapeutics Cohort
- Jan 30, 2024
- tmc.edu
TMC names 2024 cohort of cancer treatment innovators
- Jan 30, 2024
- houston.innovationmap.com
Who is Reglagene
Reglagene is a therapeutics company based in Tucson, Arizona. The company is privately held and employs 8 people. Reglagene develops brain penetrant medicines designed to create breakthrough therapies for the treatment of brain diseases. Their focus is on providing safe and effective solutions for patients suffering from various neurological disorders. Reglagene distinguishes itself through its expertise in designing and developing drugs specifically designed to cross the blood-brain barrier, a significant challenge in treating many brain diseases. This specialized knowledge allows them to create targeted therapies with potentially greater efficacy. For more information, please visit Reglagene's website at reglagene.com.
Company Leadership
Companies Similar to Reglagene
Analyze industry trends and opportunities by examining competitors and companies comparable to Reglagene, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |